Ateganosine (THIO) and our second-generation telomere targeting agents are under clinical investigation and have not yet been proven to be safe and effective.
Ateganosine (THIO) and our second-generation telomere targeting agents are under clinical investigation and have not yet been proven to be safe and effective.